Bicyclic derivatives as CETP inhibitors

Details for Australian Patent Application No. 2007247385 (hide)

Owner Novartis AG

Inventors Kishida, Masashi; Matsuura, Naoko; Umemura, Ichiro; Ohmori, Osamu; Kawahara, Eiji; Imase, Hidetomo; Iwaki, Yuki

Agent Davies Collison Cave

Pub. Number AU-B-2007247385

PCT Pub. Number WO2007/128568

Priority 60/866,480 20.11.06 US; 60/896,142 21.03.07 US; 0609268.8 10.05.06 GB

Filing date 8 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 14 July 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/128568 Priority application(s): WO2007/128568

14 July 2011 Application Accepted

  Published as AU-B-2007247385

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007247389-Stock monitoring

2007247380-Antibody-targeted cytokines for therapy